XML 50 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended 6 Months Ended
Jul. 01, 2012
Jul. 03, 2011
Jul. 01, 2012
Jul. 03, 2011
Revenues $ 18,706 $ 43,112 $ 46,207 $ 71,027
Cost of products sold 14,239 31,552 35,147 55,053
Gross profit 4,467 11,560 11,060 15,974
Operating expenses:        
Research and development (including $65, $79, $130 and $157, respectively, of amortization of intangible assets) 1,970 2,114 4,109 4,619
Selling, general, and administrative (including $60, $78, $120 and $157, respectively, of amortization of intangible assets) 5,429 6,409 11,172 12,254
Total operating expenses 7,399 8,523 15,281 16,873
Operating income (loss) (2,932) 3,037 (4,221) (899)
Other income (expense):        
Interest income 2 1 3 2
Interest expense (115) (162) (219) (318)
Miscellaneous (20) (9) 32 290
Income (loss) from continuing operations before income taxes (3,065) 2,867 (4,405) (925)
Income tax provision-current 188 63 267 67
Income tax provision (benefit)-deferred (17) 55 (5) 109
Total income taxes provision 171 118 262 176
Net income (loss) from continuing operations (3,236) 2,749 (4,667) (1,101)
Discontinued operations:        
Income (loss) from discontinued operations, net of tax 49 (2,325) (22) (4,178)
Net income (loss) (3,187) 424 (4,689) (5,279)
Net (income) loss attributable to noncontrolling interest 20 15 20 28
Net income (loss) attributable to Ultralife (3,167) 439 (4,669) (5,251)
Other comprehensive income (loss):        
Foreign currency translation adjustments (25) 60 123 287
Comprehensive income (loss) attributable to Ultralife $ (3,192) $ 499 $ (4,546) $ (4,964)
Net income (loss) attributable to Ultralife common shareholders - basic        
Continuing operations (in Dollars per share) $ (0.18) $ 0.16 $ (0.27) $ (0.06)
Discontinued operations (in Dollars per share) $ 0.00 $ (0.13) $ 0.00 $ (0.24)
Total (in Dollars per share) $ (0.18) $ 0.03 $ (0.27) $ (0.30)
Net income (loss) attributable to Ultralife common shareholders - diluted        
Continuing operations (in Dollars per share) $ (0.18) $ 0.16 $ (0.27) $ (0.06)
Discontinued operations (in Dollars per share) $ 0.00 $ (0.13) $ 0.00 $ (0.24)
Total (in Dollars per share) $ (0.18) $ 0.03 $ (0.27) $ (0.30)
Weighted average shares outstanding - basic (in Shares) 17,396,000 17,296,000 17,376,000 17,286,000
Weighted average shares outstanding - diluted (in Shares) 17,396,000 17,308,000 17,376,000 17,286,000